Teva Octreotide for injectable suspension recalled due to potential drug quality issues

Product quality

Date

2026-01-13

Country

Canada

Product

All strengths of Teva Octreotide for Injectable Suspension Kit (DIN 02503751, 02503778 and 0253786) with the lot…

Category

Drugs & medical

Source

Health Canada

Copied automatically from the Government of Canada. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

1. Check the product name, strength and lot number against the official notice.
2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the Government of Canada has the exact models, batch codes and remedy, and it takes priority.

Other drugs & medical recalls in Canada

1. 2026-01-14
2. CA
   Drugs & medicalType II

   A.T.S.® 5000TS (Tourniquet System) With Hoses And Lop Sensor (Personalized Pressure)

   Performance

   Health CanadaOfficial notice →
3. CA
   Drugs & medicalType II

   Brevera® Breast Biopsy System

   Performance

   Health CanadaOfficial notice →
4. 2026-01-13
5. CA
   Drugs & medicalType I

   Octreotide for injectable suspension; Good manufacturing practices concerns

   Product quality

   Health CanadaOfficial notice →
6. 2026-01-12
7. CA
   Drugs & medicalType III

   Locametz powder for solution, kit; Out of specification (unknown impurity)

   Product quality

   Health CanadaOfficial notice →
8. 2026-01-09
9. CA
   Drugs & medical

   Fake Cialis and Viagra seized from Bitco Distribution in Ontario

   Product safety - Unauthorized product

   Health CanadaOfficial notice →
10. 2026-01-07
11. CA
    Drugs & medicalType II

    BS 3/8x3/32 L1.7 (Bubble Sensor for 3/8” X 3/32” tubing, length 1,7 m)

    Performance

    Health CanadaOfficial notice →